Editorial · Transparency

About
This Reference

The Health Reference is an independent clinical reference for medicinal plants, dietary supplements, and natural medicine. Every page is built on primary peer-reviewed literature — not marketing claims, not anecdote, not tradition presented as evidence.

The Independent Standard for Natural Medicine Reference

The supplement and herbal medicine space is saturated with content written to sell — not to inform. Product reviews dressed as clinical guides. Affiliate roundups disguised as encyclopedias. Health claims sourced from manufacturer whitepapers rather than peer-reviewed trials.

The Health Reference was built to be the opposite. Every monograph on this site begins with the primary literature: PubMed-indexed randomised controlled trials, meta-analyses, pharmacokinetic studies, and regulatory assessments from the European Medicines Agency, the World Health Organisation, and national pharmacopoeias. Traditional use is documented accurately but never presented as clinical evidence.

When a study is inconclusive, we say so. When the evidence is weak, the evidence grade reflects that. When a supplement has documented safety risks or drug interactions, those are listed prominently — not buried in a disclaimer footnote. The goal is not to make natural medicine look good or bad. The goal is to represent what the science actually says, precisely.

Where affiliate links appear on this site, they are clearly disclosed and restricted exclusively to products that meet documented third-party quality testing standards. Commercial relationships never influence the clinical content of any monograph. The medicinal plants encyclopedia and supplements reference are written to the same standard, regardless of whether a product exists to be recommended.

What This Site Is — and Is Not

This site occupies a specific niche: clinical reference, not wellness content. The writing register is institutional and precise. Pharmacological terminology is used accurately, not approximated for general audiences. Readers are assumed to be capable of engaging with clinical information directly.

At the same time, every page is accessible to a motivated non-specialist. Where technical terminology is unavoidable, it is defined in context. The dual audience — general public and health professionals — is served simultaneously, not compromised for either.

"The supplement industry spends billions telling people what they want to hear. This reference tells people what the evidence says."

What This Site Is

  • An independent, editorially controlled clinical reference with no external ownership or sponsorship influence
  • A source of evidence-graded pharmacological data drawn from PubMed-indexed primary literature
  • A resource that distinguishes clearly between preclinical data, traditional use, and human RCT evidence
  • A site with transparent affiliate disclosure, restricted to third-party-tested products only
  • A growing encyclopedia updated as new clinical trial data emerges in the phytomedicine literature
  • A YMYL site held to the highest standards of accuracy, sourcing, and editorial accountability

What This Site Is Not

  • A source of personalised medical advice, diagnosis, or treatment recommendations for any individual
  • A platform that accepts sponsored content, paid reviews, or manufacturer-funded placements
  • A site that presents animal or in vitro studies as clinical evidence of human efficacy
  • A wellness blog that uses anecdote, tradition, or unverified claims as primary sources
  • A substitute for consultation with a qualified physician, pharmacist, or registered dietitian
  • Affiliated with any supplement manufacturer, pharmacy chain, or healthcare network

The Editorial Process

Every monograph on this site follows the same structured research and writing protocol, applied without exception.

01

Primary Literature Search

Each monograph begins with a systematic search of PubMed/MEDLINE, the Cochrane Library, and EMBASE for all relevant RCTs, systematic reviews, meta-analyses, and pharmacokinetic studies. Search terms include the plant's common name, accepted Latin binomial, and principal active constituents. No publication date cutoff is applied — historical clinical data is included where relevant to pharmacological context.

02

Regulatory & Pharmacopoeia Cross-Reference

Dosage, safety, and contraindication data is cross-referenced against the European Medicines Agency (EMA) HMPC monographs, WHO Monographs on Selected Medicinal Plants, the German Commission E, the European Pharmacopoeia, and national regulatory documents where available. Discrepancies between regulatory bodies are noted explicitly in the monograph text.

03

Evidence Grading

Each primary clinical indication carries an evidence grade following criteria comparable to those used by the Natural Standard Research Collaboration. Grade A reflects consistent, high-quality RCT evidence. Grade B reflects multiple positive trials with some inconsistency. Grade C reflects limited or conflicting clinical data. Grades are assigned conservatively — when evidence is borderline, the lower grade is applied and limitations are stated.

04

Safety & Interaction Review

Adverse event profiles, contraindications, and drug interaction data are reviewed from clinical trial safety data and post-market surveillance sources including LiverTox (NIH/NIDDK), the WHO Uppsala Monitoring Centre pharmacovigilance database, and published case reports. No plant is presented as inherently safe — safety is always contextual, dose-dependent, and population-specific.

05

Conservative Language Standards

Clinical findings are described with precision throughout. "Studies suggest" replaces "proven to." "May reduce" replaces "reduces." Study limitations — sample size, duration, population specificity, blinding quality — are noted where material to interpretation. Superlatives are avoided unless directly supported by comparative data in the cited literature.

06

Ongoing Review & Updates

Every monograph carries a Last Updated date. As new RCTs, meta-analyses, or regulatory guidance are published, relevant monographs are reviewed and updated accordingly. Evidence grades, dosage recommendations, and safety data are subject to revision without notice. The publication date of each cited study is visible in the reference list, allowing readers to assess recency independently.

Where the Evidence Comes From

The Health Reference draws exclusively on publicly accessible, peer-reviewed, and regulatory-grade sources. No manufacturer-funded white papers, no unpublished data, and no proprietary industry studies are cited as primary evidence for any clinical claim.

Database
PubMed / MEDLINE

U.S. National Library of Medicine's primary biomedical literature database. The first-line source for all RCTs, meta-analyses, and pharmacokinetic studies cited in monographs.

Regulatory
EMA — Committee on Herbal Medicinal Products (HMPC)

The European Medicines Agency's official herbal monographs. The gold standard for evidence-based traditional use approval and dosage guidance across the European Union.

Regulatory
WHO Monographs on Selected Medicinal Plants

The World Health Organisation's peer-reviewed monograph series covering pharmacology, clinical evidence, safety, and dosage for internationally used medicinal plants.

Regulatory
German Commission E

The German federal regulatory authority's expert committee monographs on herbal drugs — the foundational evidence standard for European phytomedicine for over four decades.

Safety
LiverTox — NIH / NIDDK

The National Institute of Diabetes and Digestive and Kidney Diseases' database of drug-induced liver injury, including herbal and dietary supplements. Referenced for all hepatotoxicity data.

Reference
Wikiphyto — French Phytotherapy Reference

The French-language clinical phytotherapy reference used by pharmacists and physicians. A primary source for European pharmacopoeia data and traditional use documentation.

Affiliate & Commercial Disclosure

Some pages on The Health Reference contain affiliate links to supplement products. When a visitor purchases through one of these links, The Health Reference may earn a commission at no additional cost to the purchaser. Affiliate relationships never influence the clinical content of any monograph. Evidence grades, safety data, dosage recommendations, and drug interaction summaries are determined solely by the primary literature — not by commercial relationships. Affiliate links are restricted to brands with documented third-party quality testing, including certificate of analysis transparency and current Good Manufacturing Practice (cGMP) certification. All affiliate content is clearly identified on each page.

Medical Disclaimer

The content published on The Health Reference is produced for educational and professional reference purposes only. It does not constitute medical advice, clinical diagnosis, or individualised treatment guidance. No content on this site should be used as a substitute for consultation with a qualified physician, pharmacist, registered dietitian, or other licensed healthcare provider. Supplement use — particularly in the context of existing medical conditions, pregnancy, lactation, or concurrent pharmaceutical therapy — requires professional supervision. The Health Reference accepts no liability for decisions made on the basis of content published on this site.

Corrections, Errors & Feedback

If you identify a factual error, an outdated citation, a missing drug interaction, or any other inaccuracy in our content — we want to know. Clinical accuracy is the primary obligation of this reference. Corrections are reviewed, verified against the primary literature, and applied promptly. Press enquiries and editorial collaboration requests are also welcome.